<PAGE>
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________________
AMENDMENT NO. 5
(Final Amendment)
TO
SCHEDULE 14D-1
Tender Offer Statement Pursuant to Section 14(d)(1)
of the Securities Exchange Act of 1934
AND
SCHEDULE 13D
___________________________
PSICOR, INC.
(NAME OF SUBJECT COMPANY)
BAXTER INTERNATIONAL INC.
BAXTER HEALTHCARE CORPORATION
BAXTER CVG SERVICES II, INC.
(BIDDERS)
COMMON STOCK, NO PAR VALUE
(TITLE OF CLASS OF SECURITIES)
0007449011
(CUSIP NUMBER OF CLASS OF SECURITIES)
___________________________
JAY P. WERTHEIM, ESQ.
VICE PRESIDENT, LAW
BAXTER HEALTHCARE CORPORATION
17221 RED HILL AVENUE
IRVINE, CALIFORNIA 92714
(714) 474-6415
(NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED TO
RECEIVE NOTICES AND COMMUNICATIONS ON BEHALF OF BIDDERS)
WITH A COPY TO:
JOSEPH J. GIUNTA, ESQ.
SKADDEN, ARPS, SLATE, MEAGHER & FLOM
300 SOUTH GRAND AVENUE
LOS ANGELES, CALIFORNIA 90071
TELEPHONE: (213) 687-5000
NOVEMBER 29, 1995
___________________________
DATE TENDER OFFER FIRST PUBLISHED, SENT OR GIVEN TO SECURITY HOLDERS
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>
________________________________
CUSIP No. 0007449011 14D-1
________________________________
________________________________________________________________________________
NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
1.
BAXTER INTERNATIONAL INC.
________________________________________________________________________________
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
/ / (a)
2. / / (b)
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
SOURCE OF FUNDS
4.
AF
________________________________________________________________________________
5. / / CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(e) OR 2(f)
________________________________________________________________________________
CITIZENSHIP OR PLACE OF ORGANIZATION
6.
DELAWARE
________________________________________________________________________________
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7.
4,240,231
________________________________________________________________________________
8. / / CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES CERTAIN SHARES
________________________________________________________________________________
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7)
9.
97.2%
________________________________________________________________________________
10. TYPE OF REPORTING PERSON
HC and CO
________________________________________________________________________________
2
<PAGE>
________________________________
CUSIP No. 0007449011 14D-1
________________________________
________________________________________________________________________________
NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
1.
Baxter Healthcare Corporation
________________________________________________________________________________
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
/ / (a)
2. / / (b)
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
SOURCE OF FUNDS
4.
WC
________________________________________________________________________________
5. / / CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(e) OR 2(f)
________________________________________________________________________________
CITIZENSHIP OR PLACE OF ORGANIZATION
6.
DELAWARE
________________________________________________________________________________
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7.
4,240,231
________________________________________________________________________________
8. / / CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES CERTAIN SHARES
________________________________________________________________________________
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7)
9.
97.2%
________________________________________________________________________________
10. TYPE OF REPORTING PERSON
CO
________________________________________________________________________________
3
<PAGE>
________________________________
CUSIP No. 0007449011 14D-1
________________________________
________________________________________________________________________________
NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
1.
Baxter CVG Services II, Inc.
________________________________________________________________________________
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
/ / (a)
2. / / (b)
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
SOURCE OF FUNDS
4.
AF
________________________________________________________________________________
5. / / CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(e) OR 2(f)
________________________________________________________________________________
CITIZENSHIP OR PLACE OF ORGANIZATION
6.
PENNSYLVANIA
________________________________________________________________________________
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7.
4,240,231
________________________________________________________________________________
8. / / CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES CERTAIN SHARES
________________________________________________________________________________
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7)
9.
97.2%
________________________________________________________________________________
10. TYPE OF REPORTING PERSON
CO
________________________________________________________________________________
4
<PAGE>
This Amendment No. 5 amends and supplements the Tender Offer Statement
on Schedule 14D-1 and Schedule 13D dated November 29, 1995 (as amended by
Amendments No. 1, 2, 3 and 4 thereto, the "Statement"), filed by Baxter CVG
Services II, Inc. ("Purchaser"), a Pennsylvania corporation and direct wholly
owned subsidiary of Baxter Healthcare Corporation ("Parent"), a Delaware
corporation and indirect wholly owned subsidiary of Baxter International Inc.
("International"), a Delaware corporation (Purchaser, Parent and
International, collectively, the "Bidders"), relating to Purchaser's offer to
purchase all outstanding shares of Common Stock, no par value (the "Shares")
of PSICOR, Inc., a Pennsylvania corporation (the "Company"), at $17.50 per
Share, net to the seller in cash, upon the terms and subject to the
conditions set forth in the Offer to Purchase and the related Letter of
Transmittal, copies of which were previously attached as Exhibits (a)(1) and
(a)(2) to the Statement (which are herein referred to as the "Offer").
Capitalized terms not separately defined herein shall have the meanings
specified in the Statement.
ITEM 6. INTEREST IN SECURITIES OF THE SUBJECT COMPANY.
The Bidders' Offer expired on January 25, 1996. As of January 30, 1996,
a total of 4,240,231 Shares (or approximately 97.2% of the 4,360,142 Shares
outstanding), including Shares for which certificates were delivered to the
Depositary pursuant to the Offer's guaranteed delivery procedure, had been
validly tendered and not withdrawn. The Bidders have accepted for purchase
all such Shares.
5
<PAGE>
SIGNATURE
After due inquiry and to the best of its knowledge and belief, the
undersigned certifies that the information set forth in this statement is true,
complete and correct.
Dated: January 31, 1996
BAXTER INTERNATIONAL INC.
By: /S/ HARRY M. JANSEN KRAEMER JR.
------------------------------------
Name: Harry M. Jansen Kraemer Jr.
Title: Senior Vice President
and Chief Financial Officer
6
<PAGE>
SIGNATURE
After due inquiry and to the best of its knowledge and belief, the
undersigned certifies that the information set forth in this statement is true,
complete and correct.
Dated: January 31, 1996
BAXTER HEALTHCARE CORPORATION
By: /S/ JAY P. WERTHEIM
-----------------------------------
Name: Jay P. Wertheim
Title: Vice President, Law
7
<PAGE>
SIGNATURE
After due inquiry and to the best of its knowledge and belief, the
undersigned certifies that the information set forth in this statement is true,
complete and correct.
Dated: January 31, 1996
BAXTER CVG SERVICES II, INC.
By: /S/ JAY P. WERTHEIM
-----------------------------------
Name: Jay P. Wertheim
Title: Vice President and Secretary
8
